tender for supply of srphc82281240-coronary drug eluting stents., srphc82281240-coronary drug eluting stents with (1) stent on cobalt chro mium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for a ctive drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing n eo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of t he stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. ( 5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design sh ould be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the sten t in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should b e documented / published in peer reviewed scientific journals. (10) the documents relat ed to the efficacy and safety of the stent should be only for the brand that is offere d in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. unit:no - warranty period: 30 months after the date of delivery

Latest Tender Detail from southern railway SR for the tender for supply of srphc82281240-coronary drug eluting stents., srphc82281240-coronary drug eluting stents with (1) stent on cobalt chro mium alloy or platinum chromium alloy. (2) stent with coating of polymer carrier for a ctive drug ( sirolimus everolimus or zotarolimus shown to be effective in preventing n eo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm and length of t he stent should be 12mm to 48mm. (4) the strut thickness should be 91 micron or less. ( 5) stent delivery system should be monorail (single operator exchange or rapid exchange). (6) stent should be compatible with 5fr guiding catheter (7) stent design sh ould be open cell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the sten t in terms of target vessel revascularisation (tvr) and in-situ thrombosis (ist) should b e documented / published in peer reviewed scientific journals. (10) the documents relat ed to the efficacy and safety of the stent should be only for the brand that is offere d in the tender bid (11) the manufacturer/supplier should submit proof of supply of the stent to a major government institute. unit:no - warranty period: 30 months after the date of delivery in perambalur, tamil nadu,. Reference number 15640169. Don't miss out on this chance to be part of a significant project. Register for free today to access the complete tender details and download the necessary documents. Seize the opportunity with Tender 18!